Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label influence NSCLC crizotinib response. Show all posts
Showing posts with label influence NSCLC crizotinib response. Show all posts
Thursday, March 30, 2017

ALK fusion variants could influence NSCLC crizotinib response

›
In continuation of my update on  crizotinib In non-small-cell lung cancer (NSCLC) patients with anaplastic lymphoma kinase (AL...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.